The different prognostic impact of age according to individual molecular subtypes in breast cancer-Reference-Cited by-同舟云学术

The different prognostic impact of age according to individual molecular subtypes in breast cancer

Published:2022 Issue:3 Volume:103 Page:129
ISSN:2288-6575
Container-title:Annals of Surgical Treatment and Research
language:en
Short-container-title:Ann Surg Treat Res

Author:

Kim Nam Hee¹^ORCID,Bang Hye Won¹^ORCID,Eom Yong Hwa¹^ORCID,Choi Seung Hye¹^ORCID

Affiliation:

1. Division of Breast Surgery, Department of Surgery, Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Publisher

The Korean Surgical Society

Subject

Surgery

Link

https://astr.or.kr/pdf/10.4174/astr.2022.103.3.129

Reference25 articles.

1. Breast Cancer in Young Women

2. Patients 35 years old or younger with operable breast cancer are more at risk for relapse and survival: A retrospective matched case–control study

3. Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State

4. Breast Cancer Incidence Rates in U.S. Women Are No Longer Declining

5. Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer;ESMO Open;2024-03

2. Evaluating the causal impact of reproductive factors on breast cancer risk: a multivariable mendelian randomization approach;2024-02-03

3. A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer;International Journal of Molecular Sciences;2023-10-25